Distinguished in Muscle Atrophy

Dr. Julie A. Parsons

Internal Medicine
12207 Pecos St, Suite 300, 
Westminster, CO 
Distinguished in Muscle Atrophy
12207 Pecos St, Suite 300, 
Westminster, CO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Julie Parsons is a primary care provider, practicing in Internal Medicine in Westminster, Colorado. Dr. Parsons is rated as a Distinguished provider by MediFind in the treatment of Muscle Atrophy. Her top areas of expertise are Spinal Muscular Atrophy (SMA), Primary Lateral Sclerosis, Muscle Atrophy, and Spinal Muscular Atrophy Type 2.

Her clinical research consists of co-authoring 28 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 4 articles in the study of Muscle Atrophy.

Specialties
Internal Medicine
Licenses
Internal Medicine in CO
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

12207 Pecos St, Suite 300, Westminster, CO 80031

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Escalating Dose and Randomized, Controlled Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy
Escalating Dose and Randomized, Controlled Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy
Enrollment Status: Completed
Publish Date: June 05, 2025
Intervention Type: Drug
Study Drug: Nusinersen
Study Phase: Phase 3
An Open-Label Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ISIS 396443 Delivered Intrathecally to Subjects With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy
An Open-Label Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ISIS 396443 Delivered Intrathecally to Subjects With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: Nusinersen
Study Phase: Phase 2
A Global Study of a Single, One-Time Dose of AVXS-101 Delivered to Infants With Genetically Diagnosed and Pre-symptomatic Spinal Muscular Atrophy With Multiple Copies of SMN2
A Global Study of a Single, One-Time Dose of AVXS-101 Delivered to Infants With Genetically Diagnosed and Pre-symptomatic Spinal Muscular Atrophy With Multiple Copies of SMN2
Enrollment Status: Completed
Publish Date: September 07, 2022
Intervention Type: Biological
Study Drug: Onasemnogene Abeparvovec-Xioi
Study Phase: Phase 3
Phase 3, Open-Label, Single-Arm, Single-Dose Gene Replacement Therapy Clinical Trial for Patients With Spinal Muscular Atrophy Type 1 With One or Two SMN2 Copies Delivering AVXS-101 by Intravenous Infusion
Phase 3, Open-Label, Single-Arm, Single-Dose Gene Replacement Therapy Clinical Trial for Patients With Spinal Muscular Atrophy Type 1 With One or Two SMN2 Copies Delivering AVXS-101 by Intravenous Infusion
Enrollment Status: Completed
Publish Date: August 16, 2022
Intervention Type: Biological
Study Phase: Phase 3
An Open-Label, Multi-Center, Study With a Concurrent Untreated Control Arm to Evaluate the Efficacy and Safety of Eteplirsen in Duchenne Muscular Dystrophy
An Open-Label, Multi-Center, Study With a Concurrent Untreated Control Arm to Evaluate the Efficacy and Safety of Eteplirsen in Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: January 25, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

28 Total Publications

Open-label phase 4 trial evaluating nusinersen after onasemnogene abeparvovec in children with spinal muscular atrophy.
Open-label phase 4 trial evaluating nusinersen after onasemnogene abeparvovec in children with spinal muscular atrophy.
Journal: The Journal of clinical investigation
Published: September 16, 2025
Similar Doctors
Advanced in Muscle Atrophy
Dr. Lora E. Shirar
Family Medicine | Internal Medicine
Advanced in Muscle Atrophy
Dr. Lora E. Shirar
Family Medicine | Internal Medicine

Meadows Family Medical Center Inc

5920 Mcintyre St, 
Golden, CO 
 (12.0 miles away)
Languages Spoken:
English
See accepted insurances

Lora Shirar is a primary care provider, practicing in Family Medicine and Internal Medicine in Golden, Colorado. Dr. Shirar is rated as an Advanced provider by MediFind in the treatment of Muscle Atrophy. Her top areas of expertise are Dementia, Alzheimer's Disease, Familial Hypertension, and Hypertension.

Advanced in Muscle Atrophy
Dr. Jameel R. Chohan
General Practice | Internal Medicine
Advanced in Muscle Atrophy
Dr. Jameel R. Chohan
General Practice | Internal Medicine

Meadows Family Medical Center Inc

999 17th St, Suite 500, 
Denver, CO 
 (11.6 miles away)
720-355-0539
Languages Spoken:
English
See accepted insurances

Jameel Chohan is a primary care provider, practicing in General Practice and Internal Medicine in Denver, Colorado. Dr. Chohan is rated as an Advanced provider by MediFind in the treatment of Muscle Atrophy. His top areas of expertise are Dementia, Alcoholic Neuropathy, Chronic Obstructive Pulmonary Disease (COPD), and Type 2 Diabetes (T2D).

Advanced in Muscle Atrophy
Dr. Vishal R. Patel
Family Medicine | Internal Medicine
Advanced in Muscle Atrophy
Dr. Vishal R. Patel
Family Medicine | Internal Medicine

Inpatient Consultants Of Colorado PC

2000 S Colorado Blvd, Suite 420, 
Denver, CO 
 (16.9 miles away)
720-524-1550
Experience:
17+ years
Languages Spoken:
English
See accepted insurances

Vishal Patel is a primary care provider, practicing in Family Medicine and Internal Medicine in Denver, Colorado. Dr. Patel has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Muscle Atrophy. His top areas of expertise are Cellulitis, Stroke, West Nile Virus Infection, Tissue Biopsy, and Laminectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Parsons's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile